Latest Articles
30. 11. 2020
List of reimbursed medicinal products valid as of 1.12.2020
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
13. 11. 2020
IMP with GMO for the treatment of COVID in CT 12.11.2020
Information on documentation to be submitted for clinical trials on medicinal products for the treatment of COVID-19, 7.11.2020, updated 12.11.2020
09. 11. 2020
Opinion of SÚKL's Department of Clinical Trials on Medicinal Products on Ongoing Clinical Trials and To-Be-Commenced Clinical Trials in Light of the COVID-19 Epidemiological Situation of 06 November 2020
fully superseding opinions of 28 August 2020
04. 11. 2020
Important Information for Applicants for Clinical Trials through the Voluntary Harmonisation Procedure - Brexit and Christmas Break 2020/2021
The State Institute for Drug Control hereby informs the sponsors of clinical trials that VHP Christmas Break 2020 will be from 22 December 2020 to 6 January 2021.
23. 10. 2020
VHP procedures since 23rd October 2020
Important Information for Applicants for Clinical Trials through the Voluntary Harmonisation Procedure
30. 09. 2020
List of reimbursed medicinal products valid as of 1.10.2020
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
31. 08. 2020
List of reimbursed medicinal products valid as of 1.9.2020
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...
31. 07. 2020
List of reimbursed medicinal products valid as of 1.8.2020
Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...
cz
